---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-001612"
form_type: "8-K"
ticker: "BDPT"
cik: "0001575142"
company_name: "BIOADAPTIVES, INC."
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:14:56.233132+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BioAdaptives plans reverse stock split after shares balloon 6,530% in 5 years; CEO cites turnaround

## Summary
- Shares outstanding grew from 18.6M (Jan 2020) to 1.23B (June 2024), a 6,530% increase with no revenue growth.
- Reverse split intended to lift stock from sub-penny range; ratio and effective date not yet specified.
- CEO James Keener (since management change) leading turnaround with new product lines for human and animal health.
- Company expects increased revenue and profitability from upcoming product launches through new distribution channels.
- Draft letter prematurely published by website contractor error; this press release clarifies the planned reverse split.

## SEC filing metadata
- accession: 0001640334-24-001612
- form_type: 8-K
- ticker: BDPT
- cik: 0001575142
- company_name: BIOADAPTIVES, INC.
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1575142/000164033424001612/0001640334-24-001612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1575142/000164033424001612/bdpt_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-001612
- JSON: https://secwatch.observer/filing/0001640334-24-001612.json
- Plain text: https://secwatch.observer/filing/0001640334-24-001612.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.